The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Amicus Therapeutics Inc (NASDAQ: FOLD) was $10.49 for the day, up 1.55% from the previous closing price of $10.33. In other words, the price has increased by $1.55 from its previous closing price. On the day, 1.77 million shares were traded. FOLD stock price reached its highest trading level at $10.7151 during the session, while it also had its lowest trading level at $10.45.
Ratios:
Our analysis of FOLD’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.61 and its Current Ratio is at 3.03. In the meantime, Its Debt-to-Equity ratio is 3.40 whereas as Long-Term Debt/Eq ratio is at 3.34.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on May 30, 2024, initiated with a Overweight rating and assigned the stock a target price of $18.
On May 14, 2024, Guggenheim Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $13.
Morgan Stanley Upgraded its Equal-Weight to Overweight on December 19, 2023, whereas the target price for the stock was revised from $15 to $20.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 05 ’24 when Campbell Bradley L sold 6,100 shares for $10.00 per share. The transaction valued at 61,029 led to the insider holds 886,654 shares of the business.
Campbell Bradley L sold 1,400 shares of FOLD for $14,003 on Jul 01 ’24. The President and CEO now owns 886,654 shares after completing the transaction at $10.00 per share. On Jun 03 ’24, another insider, Campbell Bradley L, who serves as the President and CEO of the company, sold 7,500 shares for $10.00 each. As a result, the insider received 75,000 and left with 886,654 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FOLD now has a Market Capitalization of 3107127552 and an Enterprise Value of 3312016128. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.34 while its Price-to-Book (P/B) ratio in mrq is 23.77. Its current Enterprise Value per Revenue stands at 7.821 whereas that against EBITDA is -67.571.
Stock Price History:
The Beta on a monthly basis for FOLD is 0.71, which has changed by -0.21716416 over the last 52 weeks, in comparison to a change of 0.23951602 over the same period for the S&P500. Over the past 52 weeks, FOLD has reached a high of $14.57, while it has fallen to a 52-week low of $9.02. The 50-Day Moving Average of the stock is 5.42%, while the 200-Day Moving Average is calculated to be -8.21%.
Shares Statistics:
FOLD traded an average of 2.47M shares per day over the past three months and 1706040 shares per day over the past ten days. A total of 293.59M shares are outstanding, with a floating share count of 288.09M. Insiders hold about 2.74% of the company’s shares, while institutions hold 106.73% stake in the company. Shares short for FOLD as of 1718323200 were 25797582 with a Short Ratio of 10.45, compared to 1715731200 on 28907764. Therefore, it implies a Short% of Shares Outstanding of 25797582 and a Short% of Float of 8.76.
